Share on StockTwits

AVEO Pharmaceuticals (NASDAQ:AVEO) posted its quarterly earnings results on Monday. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.09, Analyst Ratings Net reports.

AVEO Pharmaceuticals (NASDAQ:AVEO) traded up 0.85% during mid-day trading on Monday, hitting $1.19. 328,675 shares of the company’s stock traded hands. AVEO Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $2.37. The stock has a 50-day moving average of $1.38 and a 200-day moving average of $1.47. The company’s market cap is $61.5 million.

AVEO Pharmaceuticals, Inc is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.